Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006262-16Phase 3Active
Phase 3, randomised, double-blind trial in cocaine use disorder (CUD) comparing Modiodal with Placebo (2 arms). Primary endpoint: DAT binding potential on PET. Started Mar 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006262-16.